Precision Medicine Market share to hit $88bn by 2023 - PowerPoint PPT Presentation

Loading...

PPT – Precision Medicine Market share to hit $88bn by 2023 PowerPoint presentation | free to download - id: 85d079-OGNjY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Precision Medicine Market share to hit $88bn by 2023

Description:

Get more details @ Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics – PowerPoint PPT presentation

Number of Views:126

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Precision Medicine Market share to hit $88bn by 2023


1
Precision Medicine Market forecast to grow at
10.5 CAGR from 2016 to 2023 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Precision Medicine Market
  • Precision medicine market size is expected to
    grow at a rate of 10.5 over 2016-2023 with
    growing occurrence of chronic diseases such as
    cancer needing more personalized treatments and
    practices.
  • Precision medicine will allow doctors to predict
    more accurately the medical treatment, prevention
    strategies and remedies.
  • This process allows the researcher to analyze the
    cause of a patient at the molecular level and
    then use targeted treatments. Expanding precision
    medicine trials in cancer genomics and
    technological advancements such as
    biomarker-based test kits and next generation
    sequencing will fast-track global precision
    medicine market growth.
  • Government support for these technologies will
    further boost precision medicine market scope
    over the forecast timeframe. For example,
    Precision Medicine Initiatives (PMI) commenced by
    U.S President Barack Obama in January 2015, will
    alter the concept of medicines, revolutionizing
    the medication and diagnosis perception.

3
Continued
  • Precision medicine finds wide applications in
    oncology, immunology, respiratory systems, and
    central nervous systems.
  • Precision medicine market revenue in Central
    Nervous System (CNS) worth USD 9 billion in 2015,
    is anticipated to grow significantly over the
    timeframe, owing to its wide application in brain
    circuitry.
  • Based on technology, precision medicine market is
    segmented into big data analytics, drug
    discovery, gene sequencing, companion
    diagnostics, and bioinformatics. Drug discovery
    based precision medicine market worth USD 9
    billion in 2015, is anticipated to grow at a rate
    of 8.3 over the coming seven years.
  • North American precision medicine market is
    expected to grow significantly over the coming
    years due to favorable government regulations.
    U.S. is predicted to contribute significantly
    towards the regional share.
  • Key precision medicine industry participants
    include Laboratory Genomics of America Holdings,
    Intomics A/S, Silicon Biosystems, Eagle Genomics
    Limited, Roche, Covance, Pfizer, and Quest
    Diagnostics.

4
Europe precision medicine market size, by
application, 2013 - 2023 (USD Million)

5

Browse Full Market Research Report Precision
Medicine Market _at_ http//bit.ly/2jEWgH0
Request for a Sample of this Research report
_at_ https//www.fractovia.org/request-sample/250

6
Stay In Touch Website https//www.fractovia.org
Social Media
About PowerShow.com